GSTP1-IN-1
GSTP1-IN-1 is a selective GSTP1 inhibitor with an IC50 of 0.79 μM and a Kd of 0.63 μM. GSTP1-IN-1 inhibits the proliferation of gastric cancer cells, induces ROS production and depletes glutathione. GSTP1-IN-1 achieves systemic exposure and is well tolerated in xenograft mouse models, while inhibiting tumor growth. GSTP1-IN-1 can be used in gastric cancer-related research.
For research use only. We do not sell to patients.
- Formula: C30H28F3N7O7S
- Molecular Weight:687.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
GSTP1-IN-1 (Compound 16n) (72 h) selectively inhibits the viability of human gastric cancer cells dependent on GSTP1 expression, with an IC50 value of < 10 μM in sensitive cell lines; moreover, after 72 h of treatment, it shows no toxicity to non-cancerous cells THLE-2 and MRC-9 even at concentrations as high as 50 μM[1].
GSTP1-IN-1 (10 μM; 3 h) directly binds to endogenous GSTP1 in human AGS and HGC27 gastric cancer cells, and increases its thermal stability after pre-incubation at 10 μM for 3 h[1].
GSTP1-IN-1 (0-10 μM; 1 h) inhibits GST activity in human AGS gastric cancer cells in a dose-dependent manner, and significant inhibitory effects are observed at concentrations ≥ 3 μM after 1 hour of treatment[1].
GSTP1-IN-1 (0-10 μM; 1 h) reduces glutathione levels in human AGS gastric cancer cells in a dose-dependent manner, with a significant decrease observed at concentrations ≥ 3 μM after 1 hour of treatment[1].
GSTP1-IN-1 (0-10 μM; 1 h) dose-dependently increases the reactive oxygen species level in human AGS, HGC27 and NUGC-3 gastric cancer cells, and a significant inductive effect is observed at concentrations ≥ 1 μM after 1 hour of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c-nude (female, body weight 16-20 g, HGC27 human gastric cancer cells xenograft)[1]
-
Dosage:100 mg/kg; 200 mg/kg
-
Administration:i.p.; twice a day; for 18 consecutive days
-
Result:Achieved 58% tumor growth inhibition at 200 mg/kg.
Decreased the number of Ki67-positive proliferating cells in tumors at 100 mg/kg and 200 mg/kg.
Caused no significant body weight loss.
Chemical Information
-
Molecular Weight 687.65
-
Formula C30H28F3N7O7S
-
SMILES
O=S(C1=C(C=CC=C1)OC(F)(F)F)(N2CC(C2)CN3C4=C(N=C3C5=CC=C(CN6N=C(C)C([N+]([O-])=O)=C6C)O5)C=C(C(NC)=O)C=C4)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)